Greystone Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,389
| Closed | -$987K | – | 76 |
|
|
2022
Q2 | $987K | Sell |
8,389
-5,544
| -40% | -$652K | 0.31% | 50 |
|
|
2022
Q1 | $1.82M | Buy |
13,933
+1,785
| +15% | +$233K | 0.46% | 42 |
|
|
2021
Q4 | $1.85M | Buy |
12,148
+533
| +5% | +$81.3K | 0.44% | 48 |
|
|
2021
Q3 | $1.88M | Sell |
11,615
-4,624
| -28% | -$748K | 0.56% | 48 |
|
|
2021
Q2 | $2.66M | Buy |
16,239
+77
| +0.5% | +$12.6K | 0.66% | 48 |
|
|
2021
Q1 | $2.39M | Buy |
16,162
+1,698
| +12% | +$251K | 0.6% | 47 |
|
|
2020
Q4 | $2.5M | Buy |
+14,464
| New | +$2.5M | 0.68% | 46 |
|